FIELD: medicine.
SUBSTANCE: invention relates to medicine and can be used for prevention of experimental molybdenum nephropathy and proteinuria in rats. For this purpose, for one month "Aquadetrim" drug is administered in a dose of 3000 IU/100 g. Furthermore, starting with day 15, ammonium molybdate solution is simultaneously administered subcutaneously in dosage 50 mg/kg in metal equivalent.
EFFECT: invention reduces nephrotoxicity of ammonium molybdate in rats by creating experimental hypercalcemia.
1 cl, 2 dwg, 1 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF REDUCING NEPHROTOXICITY OF AMMONIUM MOLYBDATE | 2015 |
|
RU2588319C1 |
| METHOD FOR PREVENTION OF TOXIC ACTION OF CADMIUM IN EXPERIMENTAL ANIMALS SUFFERING CHRONIC POISONING | 2011 |
|
RU2462763C1 |
| METHOD FOR PREVENTION OF TOXIC ACTION OF CADMIUM IN EXPERIMENTAL ANIMALS SUFFERING CHRONIC POISONING | 2011 |
|
RU2462764C1 |
| METHOD FOR RELIEVING LEAD ACETATE NEPHROTOXICITY | 2010 |
|
RU2458410C1 |
| METHOD FOR PREVENTION OF NEPHROTOXIC EFFECT OF MOLYBDENUM | 2020 |
|
RU2786641C2 |
| METHOD OF PREVENTING TOXIC ACTION OF MOLYBDENUM IN EXPERIMENTAL ANIMALS IN CASE OF CHRONIC POISONING | 2009 |
|
RU2413309C1 |
| METHOD FOR RELIEVING LEAD ACETATE NEPHROTOXICITY | 2010 |
|
RU2461072C2 |
| METHOD FOR PREVENTION OF TOXIC ACTION OF CADMIUM IN EXPERIMENTAL ANIMALS SUFFERING CHRONIC POISONING | 2011 |
|
RU2461894C1 |
| METHOD OF PREVENTING TOXIC ACTION OF MOLYBDENUM IN EXPERIMENTAL ANIMALS IN CASE OF CHRONIC POISONING | 2009 |
|
RU2410767C1 |
| METHOD OF STIMULATING CHRONIC TOXIC NEPHROPATHY | 2009 |
|
RU2411588C1 |
